US Stocks
/
Dyne Therapeutics, Inc. Share Price
Dyne Therapeutics, Inc. Share Price

Dyne Therapeutics, Inc. Share Price

NASDAQ: DYN | Mid Cap
$16.65
+$0.27 (1.68%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Dyne Therapeutics, Inc. Stock Performance

Open
$16.55
Prev. Close
$16.38
Circuit Range
N/A
Day Range
$16.47 - $17.30
Year Range
$13.76 - $27.22
Volume
2,71,736
Average Traded
$16.91

Dyne Therapeutics, Inc. Share Price Today

As of 11 October 2026, Dyne Therapeutics, Inc.'s share price is $16.65. The stock opened at $16.55, compared to its previous close of $16.38. During today's trading session, Dyne Therapeutics, Inc.'s share price traded between $16.47 and $17.30, with an average price of $16.89. Over the past 52 weeks, the stock has recorded a high of $27.22 and a low of $13.76. In terms of performance, Dyne Therapeutics, Inc.'s share price has declined by 5.13% over the last six months and is down 26.29% on a year-on-year basis.

Dyne Therapeutics, Inc. Share Price Chart

$16.47$17.30
L
Show Current Price
H

Dyne Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$2.14B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.78
Revenue (TTM)
$0.00
Return On Equity (TTM)
-73.97%
Profit Margin
N/A
Debt to Equity
0.30
Quarterly Earnings Growth YoY
-65.27%

Dyne Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$108.04-$111.96-$120.85-$178.56
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-3.63%-7.94%-47.75%

Dyne Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$168.10-$235.94-$317.42-$446.21
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-40.36%-34.53%-40.57%

About Dyne Therapeutics, Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Dyne Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$15.90
$16.66
+3.25%
Sep 2026
$25.18
$16.14
-38.16%
Aug 2026
$24.59
$26.09
+3.63%
Jul 2026
$22.37
$25.18
+13.35%
Jun 2026
$18.80
$22.21
+14.90%
May 2026
$17.38
$19.33
+10.14%
Apr 2026
$18.76
$17.55
-3.15%
Mar 2026
$14.77
$18.12
+15.93%
Feb 2026
$17.93
$15.63
-12.73%
Jan 2026
$19.59
$17.91
-8.41%
Dec 2025
$21.38
$19.55
-10.79%
Nov 2025
$22.32
$21.92
-2.97%

DYN Share Price FAQs

What is Dyne Therapeutics, Inc. share price today?

chevron-up
Dyne Therapeutics, Inc. share price today is $16.65 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Dyne Therapeutics, Inc. stock?

chevron-up
The 52 week high of Dyne Therapeutics, Inc. stock is $27.22, while the 52 week low is $13.76 as of 10 Oct '26.

What is DYN's market capitalisation today?

chevron-up
DYN market capitalisation is $2.14B as of October 11, 2026, at 12:24 am IST.

What is DYN's net income for the last quarter?

chevron-up
DYN's net income for the last quarter is -178.56B USD.

What is the 5 year returns of DYN?

chevron-up
The 5 year returns of DYN is 14.75% as on 10 Oct '26.

What is the high & low stock price of DYN today?

chevron-up
DYN stock price hit a high of $17.30 and low of $16.47 as of 10 Oct '26.

Can I buy DYN shares in India?

chevron-up
Yes. You can buy DYN in India by opening an international trading account.